StartupsBasicNovadip Biosciences Raises, 10.4M for Pivotal Trial, Unlocking EIB Funds
Belgian biotech firm Novadip Biosciences has secured, 10.4 million in convertible financing, led by New Science Ventures. This funding is earmarked for a pivotal clinical trial and is expected to unlock a tranche from the European Investment Bank (EIB).
Published 1 hour ago
Read more →